Neonc Technologies Holdings, Inc. (NASDAQ:NTHI – Get Free Report)’s share price was down 15.7% on Tuesday . The company traded as low as $10.10 and last traded at $11.26. Approximately 39,700 shares were traded during trading, a decline of 11% from the average daily volume of 44,725 shares. The stock had previously closed at $13.36.
Neonc Technologies Stock Performance
About Neonc Technologies
Neonc Technologies Holdings, Inc develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing.
Featured Articles
- Five stocks we like better than Neonc Technologies
- Best Stocks Under $10.00
- Shares of RH Down Nearly 40%: Where Investors Can Turn To Now
- What is the Hang Seng index?
- Tariffs, Spin-Out, and R2 Updates Are Positive Signs for Rivian
- What is the Dogs of the Dow Strategy? Overview and Examples
- Cathie Wood Loads Up on Baidu—Is It the Right Time to Buy?
Receive News & Ratings for Neonc Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neonc Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
